Apricus Biosciences was founded in 1987 and is headquartered in San Diego, US

Report incorrect company information

Apricus Biosciences has an office in San Diego

San Diego, US (HQ)

11975 El Camino Real, Ste 300

Report incorrect company information

Apricus Biosciences's revenue was reported to be $5.76 m in FY, 2016 which is a **19.1% increase** from the previous period.

USD | |
---|---|

## Net income (Q3, 2017) | (3.8 m) |

## Market capitalization (5-Mar-2018) | 10.4 m |

## Cash (2-Mar-2018) | 8.5 m |

Apricus Biosciences's current market capitalization is $10.4 m.

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Revenue | 2.5 m | 9.3 m | 4.8 m | 5.8 m |

| 269% | (48%) | 19% | |

## Cost of goods sold | 23 k | 918 k | 922 k | 511 k |

## Gross profit | 2.5 m | 8.3 m | 3.9 m | 5.3 m |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 28 k | 5.5 m | 1.9 m | 475 k | 462 k | 1.3 m | 626 k | 464 k | 4.3 m | ||||

## Cost of goods sold | 75 k | 485 k | 233 k | 509 k | 142 k | 233 k | 93 k | 111 k | |||||

## Gross profit | 5.4 m | 1.4 m | 242 k | (47 k) | 1.1 m | 393 k | 371 k | 4.2 m | |||||

| 99% | 74% | 51% | (10%) | 89% | 63% | 80% | 97% |

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Cash | 21.4 m | 11.4 m | 3.9 m | 2.1 m |

## Accounts Receivable | 59 k | 678 k | 519 k | 530 k |

## Inventories | 336 k | 275 k | 469 k | 764 k |

## Current Assets | 22.3 m | 13.3 m | 6.3 m | 3.6 m |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 20.6 m | 22.5 m | 17.4 m | 16.2 m | 7.4 m | 5.8 m | 6.9 m | 2.7 m | 5.6 m | 3.8 m | 7.8 m | 8.5 m |

## Accounts Receivable | 35 k | 69 k | 49 k | 513 k | 664 k | 575 k | 688 k | 687 k | 398 k | |||

## Inventories | 338 k | 364 k | 377 k | 217 k | 411 k | 142 k | 405 k | 778 k | 800 k | |||

## Current Assets | 21.7 m | 23.5 m | 18.8 m | 18 m | 9.8 m | 8.2 m | 9.1 m | 4.9 m | 7.2 m | 5.1 m | 8.6 m | 8.7 m |

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Net Income | (16.9 m) | (21.8 m) | (19 m) | (7.4 m) |

## Depreciation and Amortization | 77 k | 170 k | 300 k | 289 k |

## Inventories | (341 k) | 61 k | (194 k) | (295 k) |

## Accounts Payable | (920 k) | (66 k) | 609 k | (509 k) |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | (15.6 m) | (3.3 m) | (1.4 m) | (4.5 m) | (6.4 m) | (5 m) | (2.5 m) | (3.3 m) | (7.1 m) | 8.1 m | |

## Depreciation and Amortization | 57 k | 20 k | 40 k | 102 k | |||||||

## Inventories | (338 k) | (28 k) | (41 k) | 15 k | 217 k | 411 k | 142 k | 405 k | 778 k | 800 k | |

## Accounts Payable | (1.5 m) | 67 k | 202 k | 295 k | 880 k | 446 k | 417 k | 1.1 m | 1.6 m | 1.4 m | 485 k |

USD | Y, 2017 |
---|---|

## Financial Leverage | 1.4 x |

Report incorrect company information